| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/22/2010 | US7741519 Bis-aryl sulfonamides |
| 06/22/2010 | US7741480 Process for the preparation of linezolid and related compounds |
| 06/22/2010 | US7741350 Bicyclic pyrazolo-heterocycles |
| 06/22/2010 | US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/22/2010 | US7741341 Benzimidazole-derivatives as factor Xa inhibitors |
| 06/22/2010 | US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer |
| 06/22/2010 | US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines |
| 06/22/2010 | US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 06/22/2010 | US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds |
| 06/22/2010 | US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction |
| 06/22/2010 | US7741316 Pharmacological uses of azetidine derivatives |
| 06/22/2010 | US7740074 Tree mounted well flow interface device |
| 06/22/2010 | CA2579915C Indole derivatives and their use as inhibitors of p53-mdm2 interaction |
| 06/22/2010 | CA2462149C Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 06/22/2010 | CA2444198C Nociceptin analogs |
| 06/22/2010 | CA2412718C Viral polymerase inhibitors |
| 06/22/2010 | CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 06/22/2010 | CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 06/17/2010 | WO2010068775A2 Alkyne antagonists of lysophosphatidic acid receptors |
| 06/17/2010 | WO2010068760A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 06/17/2010 | WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2 |
| 06/17/2010 | WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 06/17/2010 | WO2010067085A2 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates |
| 06/17/2010 | WO2010066709A1 Novel pyridinyl acrylamide derivatives |
| 06/17/2010 | WO2010066697A1 Fungicide hydroximoyl-heterocycles derivatives |
| 06/17/2010 | WO2010066684A2 Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease |
| 06/17/2010 | WO2010049915A8 Poly-heteroaryl derivatives for the treatment of cancer |
| 06/17/2010 | WO2010047737A3 Antimicrobial indoline compounds for treatment of bacterial infections |
| 06/17/2010 | WO2010025295A3 Compounds that modulate intracellular calcium |
| 06/17/2010 | US20100152457 Intermediate compound for synthesis of viridiofungin a derivative |
| 06/17/2010 | US20100152456 Intermediate compound for synthesis of viridiofungin a derivative |
| 06/17/2010 | US20100152453 Novel Compounds and Preparation for Montelukast Sodium |
| 06/17/2010 | US20100152445 Inhibitors of Diacylglycerol Acyltransferase |
| 06/17/2010 | US20100152443 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient |
| 06/17/2010 | US20100152442 4-anilino quinazoline derivatives as antiproliferative agents |
| 06/17/2010 | US20100152439 Production method |
| 06/17/2010 | US20100152255 Organic Compounds |
| 06/17/2010 | US20100152246 5-Oxoisoxazoles as inhibitors of lipases and phospholipases |
| 06/17/2010 | US20100152235 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 06/17/2010 | US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/17/2010 | US20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors |
| 06/17/2010 | US20100152190 Substituted Pyrrolidine-2-Carboxamides |
| 06/17/2010 | US20100152189 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3[4-(3-oxo-4-morpholinyl(-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 06/17/2010 | US20100152188 Novel Heterocyclic Compounds |
| 06/17/2010 | US20100152186 Triazolyl pyridyl benzenesulfonamides |
| 06/17/2010 | US20100152185 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 06/17/2010 | US20100152184 Pharmaceutical compounds |
| 06/17/2010 | US20100152183 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/17/2010 | US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors |
| 06/17/2010 | US20100152181 Amino pyrazole compound |
| 06/17/2010 | US20100152178 Imidazole derivatives |
| 06/17/2010 | US20100152169 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 06/17/2010 | US20100152167 Pyrimidine derivatives |
| 06/17/2010 | US20100152166 Compounds and methods for modulating fxr |
| 06/17/2010 | US20100152160 Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands |
| 06/17/2010 | US20100152157 6-CYCLOAMINO-3-(PYRIDAZIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND DERIVATIVES THEREOF PREPARATION AND THERAPEUTIC APPLICATION THEREOF |
| 06/17/2010 | US20100152155 Histone Deacetylase Inhibitors |
| 06/17/2010 | US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 06/17/2010 | US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases |
| 06/17/2010 | US20100152112 Quinoline derivatives as p13 kinase inhibitors |
| 06/17/2010 | US20100152047 Piperazine Compounds Whith a Herbicidal Action |
| 06/17/2010 | US20100151011 Solid orally administerable pharmaceutical dosage forms with rapid active principle release |
| 06/17/2010 | CA2746264A1 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 06/17/2010 | CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2 |
| 06/17/2010 | CA2745922A1 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease |
| 06/16/2010 | EP2196469A1 Conjugates with anti-inflammatory activity |
| 06/16/2010 | EP2195311A1 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 06/16/2010 | EP2195296A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 06/16/2010 | EP2195288A2 Small molecule bradykinin b1 receptor antagonists |
| 06/16/2010 | EP2194986A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 06/16/2010 | EP2194983A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 06/16/2010 | EP2194982A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 06/16/2010 | EP2013202B1 Substituted pyrazinone derivatives for use as a medicine |
| 06/16/2010 | EP1981858B1 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents |
| 06/16/2010 | EP1966167B1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof |
| 06/16/2010 | EP1863802B1 Substituted piperidines as renin inhibitors |
| 06/16/2010 | CN1982308B Substituted pyrazoles |
| 06/16/2010 | CN1871234B 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible NO-synthase |
| 06/16/2010 | CN1867566B Aminopyrones and their use as ATM inhibitors |
| 06/16/2010 | CN1803798B Method for producing fungicide compand |
| 06/16/2010 | CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 06/16/2010 | CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 06/16/2010 | CN101743244A Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
| 06/16/2010 | CN101743243A Compounds and compositions as ITPKB inhibitors |
| 06/16/2010 | CN101743242A Heterocyclic compounds useful as RAF kinase inhibitors |
| 06/16/2010 | CN101743241A pyridazinone derivates |
| 06/16/2010 | CN101743239A cyanoisoquinoline |
| 06/16/2010 | CN101743237A condensed anthranilamide insecticides |
| 06/16/2010 | CN101743233A Benzoxazine containing compositions of matter and curable compositions made therewith |
| 06/16/2010 | CN101743232A compounds and methods for modulating fxr |
| 06/16/2010 | CN101743231A Isoxazoline compounds and their use in pest control |
| 06/16/2010 | CN101743224A 7-substituted indole mcl-1 inhibitors |
| 06/16/2010 | CN101735210A N-substituted oxadiazine compounds with insecticidal and bactericidal activities, preparation method thereof and use thereof |
| 06/16/2010 | CN101735209A Method for synthesizing chiral dorzolamide hydrochloride |
| 06/16/2010 | CN101735208A Method for synthesizing Iloperidone |
| 06/16/2010 | CN101099286B Method and installation means for installing an electrical machine |
| 06/16/2010 | CN101048403B Heterocyclic antiviral compounds |
| 06/15/2010 | US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 06/15/2010 | US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury |
| 06/15/2010 | US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide |